Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)

NCT02226965

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Long Beach Memorial Medical Center Long Beach, California, United States
  • University of Southern California Los Angeles, California, United States
  • Colorado Blood and Cancer Institute Denver, Colorado, United States
  • Lynn Cancer Institute Boca Raton, Florida, United States
View all 27 locations
View Trial Details
Completed

Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma

NCT00274924

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Front Range Cancer Specialists Fort Collins, Colorado, United States
  • Baptist Cancer Institute - Jacksonville Jacksonville, Florida, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
View all 104 locations
View Trial Details
Completed

Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients

NCT03028103

Conditions
Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Columbia University Medical Center New York, United States
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma

NCT03364231

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations
  • TG Therapeutics Investigational Trial Site Washington D.C., District of Columbia, United States
  • TG Therapeutics Investigational Trial Site Boston, Massachusetts, United States
  • TG Therapeutics Investigational Trial Site Hackensack, New Jersey, United States
  • TG Therapeutics Investigational Trial Site New York, United States
View Trial Details
Completed

Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma

NCT02285062

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Local Institution - 177 Fayetteville, Arkansas, United States
  • Local Institution - 136 Orange, California, United States
  • Local Institution - 127 Sacramento, California, United States
  • Local Institution - 169 New Haven, Connecticut, United States
View all 158 locations
View Trial Details

Related conditions